Inventor · disambiguated record
Vijay K. Kuchroo
Also filed as: KUCHROO VIJAY · KUCHROO VIJAY K · KUCHROO VIJAY KUMAR
33 granted patents·41 pending applications·764 citations·filing 1998–2025
96Inventor score
Files withBRIGHAM & WOMENS HOSPITAL INC22BROAD INST INC22BRIGHAM & WOMENS HOSPITAL14KUCHROO VIJAY K4DANA FARBER CANCER INST INC3
Top patents by PatentIndex Score
74 records- 0198US6207156B1Specific antibodies and antibody fragmentsBRIGHAM & WOMENS HOSPITAL·Filed 1998·Granted Mar 27, 2001·431 cites·24 claims
- 0297US9163087B2Bi-specific antibodies against TIM-3 and PD-1 for immunotherapy in chronic immune conditionsKUCHROO VIJAY K·Filed 2011·Granted Oct 20, 2015·111 cites·5 claims
- 0395US8101176B2Compositions and methods related to TIM-3, a TH1-specific cell surface moleculeKUCHROO VIJAY K·Filed 2008·Granted Jan 24, 2012·46 cites·20 claims
- 0494US9333256B2Methods related to TIM 3, a Th1-specific cell surface molecule, for activating antigen presenting cellsBRIGHAM & WOMENS HOSPITAL·Filed 2014·Granted May 10, 2016·21 cites·10 claims
- 0594US7470428B2Compositions and methods related to TIM-3, a Th1-specific cell surface moleculeBRIGHAM & WOMENS HOSPITAL·Filed 2003·Granted Dec 30, 2008·59 cites·10 claims
- 0693US10934352B2Bi-specific antibodies against Tim-3 and PD-1 for immunotherapy in chronic immune conditionsBRIGHAM & WOMENS HOSPITAL INC·Filed 2017·Granted Mar 2, 2021·6 cites·17 claims
- 0793US8697069B2Methods related to TIM 3, a Th1-specific cell surface molecule, for activating antigen presenting cellsKUCHROO VIJAY K·Filed 2011·Granted Apr 15, 2014·22 cites·11 claims
- 0892US9834607B2Bi-specific antibodies against Tim-3 and PD-1 for immunotherapy in chronic immune conditionsBRIGHAM & WOMENS HOSPITAL INC·Filed 2015·Granted Dec 5, 2017·10 cites·1 claims
- 0986US8329660B2Tim-3 ligands and methods thereofKUCHROO VIJAY K·Filed 2004·Granted Dec 11, 2012·33 cites·8 claims
- 1085US10822587B2T cell balance gene expression, compositions of matters and methods of use thereofBROAD INST INC·Filed 2015·Granted Nov 3, 2020·4 cites·4 claims
- 1182US7741271B2Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 functionBRIGHAM & WOMENS HOSPITAL·Filed 2005·Granted Jun 22, 2010·6 cites·12 claims
- 1280US7553939B2T cell regulatory genes and methods of use thereofUNIV LELAND STANFORD JUNIOR·Filed 2002·Granted Jun 30, 2009·12 cites·3 claims
- 1378US2025223357A1Bi-specific antibodies against tim-3 and pd-1 for immunotherapy in chronic immune conditionsBRIGHAM & WOMENS HOSPITAL INC·Filed 2025·Application pending·0 cites
- 1475US9962440B2Methods related to TIM 3, a TH1-specific cell surface molecule, for activating antigen presenting cellsBRIGHAM & WOMENS HOSPITAL INC·Filed 2014·Granted May 8, 2018·1 cites·17 claims
- 1575US9346876B2TIM-3 ligands and methods of modulating immune responsesBRIGHAM & WOMENS HOSPITAL·Filed 2014·Granted May 24, 2016·2 cites·7 claims
- 1672US2021332130A1Bi-specific antibodies against tim-3 and pd-1 for immunotherapy in chronic immune conditionsBRIGHAM & WOMENS HOSPITAL INC·Filed 2021·Application pending·0 cites
- 1771US2024101694A1Regulators of b cell-mediated immunosuppressionTHE BRIGHAM AND WOMEN’S HOSPITAL INC·Filed 2023·Application pending·0 cites
- 1870US11884717B2Method of treating autoimmune disease with lymphocyte antigen CD5-like (CD5L) proteinBRIGHAM & WOMENS HOSPITAL INC·Filed 2021·Granted Jan 30, 2024·0 cites·2 claims
- 1964US2024262909A1Tim-3 modulates anti-tumor immunity by regulating inflammasome activationBRIGHAM & WOMENS HOSPITAL INC·Filed 2022·Application pending·0 cites
- 2064US2018271977A1Methods related to tim 3, a th1-specific cell surface molecule, for activating antigen presenting cellsBRIGHAM & WOMENS HOSPITAL INC·Filed 2018·Application pending·0 cites
- 2163US2014242094A1Methods related to tim 3, a th1-specific cell surface molecule, for activating antigen presenting cellsDANA FARBER CANCER INST INC·Filed 2014·Application pending·0 cites
- 2261US12421557B2Methods for predicting outcomes and treating colorectal cancer using a cell atlasBROAD INST INC·Filed 2020·Granted Sep 23, 2025·0 cites·16 claims
- 2361US11001622B2Method of treating autoimmune disease with lymphocyte antigen CD5-like (CD5L) proteinBRIGHAM & WOMENS HOSPITAL INC·Filed 2016·Granted May 11, 2021·0 cites·2 claims
- 2460US11209440B2T cell balance gene expression, compositions of matters and methods of use thereofBROAD INST INC·Filed 2016·Granted Dec 28, 2021·0 cites·4 claims
- 2560US2015284459A1Methods for modulating immune responses during chronic immune conditions by targeting il-27 induced pathwaysBRIGHAM & WOMENS HOSPITAL·Filed 2013·Application pending·0 cites
- 2658US11957695B2Methods and compositions targeting glucocorticoid signaling for modulating immune responsesBROAD INST INC·Filed 2019·Granted Apr 16, 2024·0 cites·12 claims
- 2758US2024167041A1Loss of lipid kinase pi5p4k gamma restricts tumor growthCANTLEY LEWIS C·Filed 2022·Application pending·0 cites
- 2858US2015079085A1Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 functionBRIGHAM & WOMENS HOSPITAL·Filed 2014·Application pending·0 cites
- 2958US2020095284A1Modulation of the immune responseBRIGHAM & WOMENS HOSPITAL INC·Filed 2019·Application pending·0 cites
- 3057US12049643B2Methods and compositions for modulating cytotoxic lymphocyte activityBROAD INST INC·Filed 2018·Granted Jul 30, 2024·0 cites·19 claims
- 3157US11793787B2Methods and compositions for enhancing anti-tumor immunity by targeting steroidogenesisBROAD INST INC·Filed 2020·Granted Oct 24, 2023·0 cites·2 claims
- 3257US10513540B2Modulation of the immune responseBRIGHAM & WOMENS HOSPITAL INC·Filed 2013·Granted Dec 24, 2019·0 cites·8 claims
- 3356US11981922B2Methods and compositions for the modulation of cell interactions and signaling in the tumor microenvironmentDANA FARBER CANCER INST INC·Filed 2020·Granted May 14, 2024·0 cites·14 claims
- 3456US2024108689A1Modulation of a pathogenic phenotype in th1 cellsBRIGHAM & WOMENS HOSPITAL INC·Filed 2022·Application pending·0 cites
- 3555US2019345446A1Compositions and methods for modulating th-17 and th-1 cell balanceBROAD INST INC·Filed 2019·Application pending·0 cites
- 3654US12447213B2Modulation of novel immune checkpoint targetsBRIGHAM & WOMENS HOSPITAL INC·Filed 2017·Granted Oct 21, 2025·0 cites·15 claims
- 3754US2021130438A1Pan-cancer t cell exhaustion genesBROAD INST INC·Filed 2020·Application pending·0 cites
- 3854US2019040154A1Methods and compositions for treatment of immune-related diseases or disorders and/or therapy monitoringBRIGHAM & WOMENS HOSPITAL INC·Filed 2018·Application pending·0 cites
- 3954US2013195895A1Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 functionBRIGHAM & WOMENS HOSPITAL·Filed 2013·Application pending·0 cites
- 4053US11186825B2Compositions and methods for evaluating and modulating immune responses by detecting and targeting POU2AF1BROAD INST INC·Filed 2018·Granted Nov 30, 2021·0 cites·20 claims
- 4153US11180730B2Compositions and methods for evaluating and modulating immune responses by detecting and targeting GATA3BROAD INST INC·Filed 2018·Granted Nov 23, 2021·0 cites·20 claims
- 4253US9732320B2Selective differentiation, identification, and modulation of human TH17 cellsBRIGHAM & WOMENS HOSPITAL INC·Filed 2014·Granted Aug 15, 2017·0 cites·1 claims
- 4352US2020081017A1T cell balance gene expression, compositions of matters and methods of use thereofBRIGHAM & WOMENS HOSPITAL INC·Filed 2019·Application pending·0 cites
- 4452US2019225701A1Regulators of b cell-mediated immunosuppressionBRIGHAM & WOMENS HOSPITAL INC·Filed 2017·Application pending·0 cites
- 4551US2022144950A1Targeting regulatory b cells and their regulators for cancer immunotherapyBRIGHAM & WOMENS HOSPITAL INC·Filed 2020·Application pending·0 cites
- 4651US2011059106A1Methods for modulating a population of myeloid-derived suppressor cells and uses thereofBRIGHAM & WOMENS HOSPITAL·Filed 2009·Application pending·0 cites
- 4750US12241053B2Modulation of novel immune checkpoint targetsBRIGHAM & WOMENS HOSPITAL INC·Filed 2016·Granted Mar 4, 2025·0 cites·17 claims
- 4850US11427869B2T cell balance gene expression, compositions of matters and methods of use thereofBROAD INST INC·Filed 2017·Granted Aug 30, 2022·0 cites·5 claims
- 4950US8410053B2Methods for treating autoimmune disorders, and reagents related theretoBACHOVCHIN WILLIAM W·Filed 2002·Granted Apr 2, 2013·0 cites·11 claims
- 5050US2022105135A1Methods and compositions for the modulation of opioid signaling in the tumor microenvironmentBROAD INST INC·Filed 2021·Application pending·0 cites
Showing the top 50 of 74 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Vijay K. Kuchroo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →